Safety of quinolones [5]

Lancet

Volumn 352, Issue 9136, 1998, Pages 1313-

  Stahlmann, R ^a   Lode, H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; PIVMECILLINAM; QUINOLONE DERIVATIVE; 4 QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ARTHROPATHY; CHILD; DRUG SAFETY; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; CONNECTIVE TISSUE; DRUG EFFECT; JOINT; NOTE;

4-QUINOLONES; ANTI-INFECTIVE AGENTS; CHILD; CONNECTIVE TISSUE; HUMANS; JOINTS;

EID: 0032541780     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70526-2     Document Type: Letter

References (4)

1. Salam MA Dhar U Khan WA Bennish ML Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis Lancet 352 1998 522 527
2. Stahlmann R Lode H Safety overview. Toxicity, adverse effects, and drug interactions Andriole VT The quinolones 2nd edn. 1998 Academic Press San Diego 369 414
3. Schlüter G Toxicology of ciprofloxacin Neu HC Weuta H First international ciprofloxacin workshop. Proc Excerpta Medica 1986 Elsevier Amsterdam 61 70
4. Pertuiset E Lenoir G Jehanne M Douchan F Guillot M Menkes CJ Tolerance articulaire de la pefloxacine et de I'ofloxacine chez les enfants et adolescents atteints de mucoviscidose Rev Rheumatol 56 1989 735 740